EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficacy and safety of mitoxantrone hydrochloride liposome/ thiotepa/ busulfan/fludarabine (MTBF) conditioning regimen for salvage allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory acute myeloid leukemia: A single - Arm prospective clinical trial

Juan Ren, Tongxin Zhang, Yuqi Wang, Huachao Zhu, Ruimin Liu, Pengcheng He, Xiaoning Wang iD

Cell Transplantation · 2026-07 · 35

DOI: 10.1177/09636897261469013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Transplantation, online erschienen am 14.07.2026. Verfasst von Juan Ren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, PR.China. Hauptthemen laut MEDLINE: Busulfan, Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Mitoxantrone. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinical Medical Research Center Project of Xi’an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To investigate the efficacy and safety of MTBF as conditioning regimen for salvage allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with relapsed or refractory acute myeloid leukemia (R/R AML). We conducted a single-arm prospective clinical trial (NCT06385808). The main outcome was cumulative incidence of relapse (CIR), and the secondary outcomes were progression-free survival (PFS), overall survival (OS), engraftment time, graft-versus-host disease (GVHD), and non-hematological adverse effects. Twenty-four R/R AML patients from the First Affiliated Hospital of Xi’an Jiaotong University were enrolled, and all achieved engraftment. Mucositis was the predominant toxicity and was managed appropriately. The two-year CIR was 10%. The two-year OS and PFS were 78.9 ± 11.1% and 51.2 ± 19.3%, respectively. Two patients experienced relapse, and three patients died of infection. Subgroup analyses demonstrated that maintenance treatment post-transplantation may improve OS. The MTBF regimen for salvage allo-HSCT in R/R AML exhibited notable anti-leukemia activity and tolerable toxicity. (NCT06385808, Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BusulfanHematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteMitoxantroneSalvage TherapyTransplantation ConditioningVidarabineAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultLiposomesProspective StudiesRecurrenceThiotepaTransplantation, Homologous

Stichwörter der Autor:innen

allogeneic hematopoietic stem cell transplantationconditioning regimenmitoxantrone hydrochloride liposomerefractory/relapsed acute myeloid leukemia

Substanzen

BusulfanfludarabineLiposomesMitoxantroneThiotepaVidarabine

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, PR.China.

ORCID-Profile: Xiaoning Wang

Förderung

  • Clinical Medical Research Center Project of Xi’an Jiaotong University

Zitieren

APA

Ren, J., Zhang, T., Wang, Y., Zhu, H., Liu, R., He, P., & Wang, X. (2026). Efficacy and safety of mitoxantrone hydrochloride liposome/ thiotepa/ busulfan/fludarabine (MTBF) conditioning regimen for salvage allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory acute myeloid leukemia: A single - Arm prospective clinical trial. Cell Transplantation, 35. https://doi.org/10.1177/09636897261469013

Vancouver

Ren J, Zhang T, Wang Y, Zhu H, Liu R, He P, et al. Efficacy and safety of mitoxantrone hydrochloride liposome/ thiotepa/ busulfan/fludarabine (MTBF) conditioning regimen for salvage allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory acute myeloid leukemia: A single - Arm prospective clinical trial. Cell Transplantation. 2026;35. doi:10.1177/09636897261469013

BibTeX
@article{Ren2026,
  author = {Ren, Juan and Zhang, Tongxin and Wang, Yuqi and Zhu, Huachao and Liu, Ruimin and He, Pengcheng and Wang, Xiaoning},
  title = {Efficacy and safety of mitoxantrone hydrochloride liposome/ thiotepa/ busulfan/fludarabine (MTBF) conditioning regimen for salvage allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory acute myeloid leukemia: A single - Arm prospective clinical trial},
  journal = {Cell Transplantation},
  year = {2026},
  volume = {35},
  doi = {10.1177/09636897261469013}
}
Kostenlos starten →